Venous thromboembolism in an oncology patient
Authors:
A. Uhrinová; P. Gavornik; I. Vacula
Authors‘ workplace:
II. interná klinika Lekárskej fakulty UK a FNsP Bratislava, Slovenská republika, prednosta prof. MUDr. Andrej Dukát, CSc., FESC
Published in:
Vnitř Lék 2009; 55(6): 599-603
Category:
Case Reports
Overview
Venous thromboembolism is a common complication in many patients with different types of malignant tumors. In this paper we describe a case of a patient with cancer in remission, who developed pulmonary embolism.
Key words:
pulmonary embolism – malignancy
Sources
1. Trousseau A. Phlegmasia alba dolens. Clinique medicinale de l’Hotel Dieu de Paris. Paris: J-B Baillière § Fils 1865: 645–712.
2. Lee AY. Management of thrombosis in cancer: primary prevention and secondary prophylaxis. Br J Haematol 2005; 128: 291–302.
3. Prandoni P. Acquired risk factors for venous thromboembolism in medical patients. Pathophysiol Haemost Thromb 2006; 35: 128–132.
4. Büller HR, van Doormaal FF, van Sluis GL et al. Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost 2007; 5 (Suppl 1): 246–254.
5. Alcalay A, Wun T, Khatri V et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol 2006; 24: 1112–1118.
6. American College of Emergency Physicians Clinical Policies Committee. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected pulmonary embolism. Ann Emerg Med 2003; 41: 257–270.
7. Righini M, Perrier A, De Moerloose P et al. D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost 2008; 6: 1059–1071.
8. Lee AY. Venous thromboembolism and cancer: prevention and therapy. Vnitř Lék 2006; 52 (Suppl 1): 127–131.
9. Hirmerová J. Optimální délka antikoagulační léčby po žilní tromboembolické příhodě: obecný či individualizovaný přístup? Vnitř Lék 2007; 53: 662–668.
10. Lee AY, Levine MN, Baker RI et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146–153.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2009 Issue 6
Most read in this issue
- The treatment of renal failure in multiple myeloma
- Is confirmation of an adrenal adenoma in patients with primary aldosteronism sufficient for indication of adrenalectomy?
- Venous thromboembolism in an oncology patient
- Application of warfarin pharmacogenetics